These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5656614)

  • 21. Preservative combinations: a microbiological assessment.
    Wakely JH; Hall NC; Krezanoski JZ
    Bull Parenter Drug Assoc; 1967; 21(4):124-35. PubMed ID: 6045458
    [No Abstract]   [Full Text] [Related]  

  • 22. Determining osmolarities: a practical approach for multicomponent intravenous and parenteral nutrient solutions.
    Gatlin L; Kulkarni P; Hussain A; DeLuca PP
    Am J Hosp Pharm; 1979 Oct; 36(10):1357-61. PubMed ID: 116545
    [No Abstract]   [Full Text] [Related]  

  • 23. Formulation of a parenteral antimalarial solution--a French undergraduate project in industrial pharmacy.
    Jeannin C; Pourcelot Y
    Am J Pharm Educ; 1977 Feb; 41(1):59-61. PubMed ID: 10236632
    [No Abstract]   [Full Text] [Related]  

  • 24. [Basic rules for the production of infusion solutions and in the ensuring of their quality].
    Ganshirt KH; Pauli W; Rössler R
    Klin Anasthesiol Intensivther; 1977; (14):1-17. PubMed ID: 926675
    [No Abstract]   [Full Text] [Related]  

  • 25. A study of particulate matter in I.V. infusion fluids.
    Davis NM; Turco S; Sivelly E
    Am J Hosp Pharm; 1970 Oct; 27(10):822-6. PubMed ID: 5473472
    [No Abstract]   [Full Text] [Related]  

  • 26. A PROPOSED MICROBIOLOGICAL METHOD FOR STUDYING THE STABILITY OF PRESERVATIVES IN PARENTERAL SOLUTIONS.
    EISMAN PC; JACONIA D; LAZARUS J
    Bull Parenter Drug Assoc; 1963; 17():10-7. PubMed ID: 14059429
    [No Abstract]   [Full Text] [Related]  

  • 27. Predicting pharmaceutical incompatibilities of parenteral medications.
    Carlin HS; Perkins AJ
    Am J Hosp Pharm; 1968 Jun; 25(6):270-9. PubMed ID: 5656772
    [No Abstract]   [Full Text] [Related]  

  • 28. Particulate contamination in New Zealand intravenous solutions.
    Passl WJ; Waring JM
    N Z Med J; 1980 Mar; 91(655):177-9. PubMed ID: 6929987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parameter for assessing parenteral cleanliness based on particle-size distributions.
    Blanchard J; Schwartz JA; Byrne DM
    J Pharm Sci; 1977 Aug; 66(8):1083-6. PubMed ID: 894493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane filtration during administration of infusion fluids for elimination of particulate matter.
    Ernerot L; Sandell E
    Acta Pharm Suec; 1967 Nov; 4(5):293-6. PubMed ID: 6081466
    [No Abstract]   [Full Text] [Related]  

  • 31. A new batch method of preparing intravenous piggyback solutions in polyvinylchloride containers.
    Levy R; Kleinberg M; Lee P
    Hosp Pharm; 1980 Oct; 15(10):504-6. PubMed ID: 10309298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2.
    Allen LV; Stiles ML
    Am J Hosp Pharm; 1981 Mar; 38(3):380-1. PubMed ID: 7223755
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the use of sorbitol in the production of infusion solutions].
    Dittmer HH; Trekel D
    Pharm Prax; 1965; 9():206-8. PubMed ID: 5888288
    [No Abstract]   [Full Text] [Related]  

  • 35. Parenteral formulations.
    Holm R
    Eur J Pharm Sci; 2024 Sep; 200():106841. PubMed ID: 38908414
    [No Abstract]   [Full Text] [Related]  

  • 36. [The foreign particles in injectable solutions].
    Cavatorta L; Pietra E; Allievi R
    Boll Chim Farm; 1969 Aug; 108(8):488-98. PubMed ID: 5354286
    [No Abstract]   [Full Text] [Related]  

  • 37. Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
    Kirschenbaum HL; Aronoff W; Piltz GW; Perentesis GP; Cutie AJ
    Am J Hosp Pharm; 1983 Oct; 40(10):1690-1. PubMed ID: 6638033
    [No Abstract]   [Full Text] [Related]  

  • 38. Physiochemical stability of pharmaceutical phosphate buffer solutions. IV. Prevention of precipitation in parenteral phosphate solutions.
    Hasegawa K; Hashi K; Okada R
    J Parenter Sci Technol; 1982; 36(5):210-5. PubMed ID: 6927750
    [No Abstract]   [Full Text] [Related]  

  • 39. [Infusion solutions. I. Nomograms for calculation of the sodium chloride content according to the Czechoslovak pharmacopoeia 3d Ed. and standard No. 864420].
    Krepinský J
    Cesk Farm; 1971 Mar; 20(2):43-8. PubMed ID: 5550001
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous versus intermittent intravenous antibiotics.
    Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.